Utah State University

DigitalCommons@USU
Undergraduate Honors Capstone Projects

Honors Program

5-2019

Manipulation of Ovarian Function Significantly Influenced Glucose
Metabolism in CBA/J Mice
Kyleigh Ann Tyler
Utah State University

Follow this and additional works at: https://digitalcommons.usu.edu/honors
Part of the Dairy Science Commons, and the Other Medicine and Health Sciences Commons

Recommended Citation
Tyler, Kyleigh Ann, "Manipulation of Ovarian Function Significantly Influenced Glucose Metabolism in CBA/
J Mice" (2019). Undergraduate Honors Capstone Projects. 527.
https://digitalcommons.usu.edu/honors/527

This Thesis is brought to you for free and open access by
the Honors Program at DigitalCommons@USU. It has
been accepted for inclusion in Undergraduate Honors
Capstone Projects by an authorized administrator of
DigitalCommons@USU. For more information, please
contact digitalcommons@usu.edu.

MANIPULATION OF OVARIAN FUNCTION SIGNIFICANTLY
INFLUENCED GLUCOSE METABOLISM IN CBA/J MICE

by
Kyleigh Ann Tyler
Capstone submitted in partial fulfillment
of the requirements for graduation with
UNIVERSITY HONORS
with a major in
Animal, Dairy, and Veterinary Science in the Department of Animal , Dairy and
Veterinary Science

Approved:

Capstone Mentor
Dr. Jeff Mason

Departmental Honors Advisor
Dr. Lee Rickords

Director of University Honors Program
Dr. Kristine Miller

UTAH STATE UNIVERSITY
Logan, UT
Spring 2019

Copyright 2019 Kyleigh Tyler
- 1-

Table of Contents

Abstract ..... ....................

....................

Introduction ........ ....... ....................

..... ...................
......................

..........................

.... .........................

.. ........ 3
.............. 3

Materials and Methods .............................................................................
Experimental Design ... ... .... .•.................

.... .....................

... ... .....................

Surgical Procedures ....... ......................................................
Exclusion Criteria ... ... ... .........................

......... 4
.... . ... 5

.. .....................

... .................................

......7

.. ....................

8

Metabolic Function-Glucose Test ..........................................................................

8

Statistical Analysis ... ...........

8

Results ...........

................

...... ......... ............

... ... ...... . .. ..........................

Discussion ..................................
Conclusions .....................

...........

... ... .. ....... .. .................

.. ............................

....... ..... .. .......... 9

..................................

... ... . .............. 10

....... .. ...... .......... .. .. .. ... ...........

... ... .... .... .. ..............

...11

Ackn ow led gm en t .... .... .... .. .. ...... ... ...... ..... .. ... ........ ... .. ..... . ...... ... .... .... ..... .......... 13
References ......... ... ............................................
Author Biography ............

.... ..... ...................

-2-

. ... ... ...... ... .... .. ....... ...............
...................................

14

... ... ........ . 15

Abstract
Menopause is assoc iated with a decline in overall health in women. One health aspect
imp acted is glucose metabolism. As women experience menopause, their metabolism declines
dramatically. The current study addressed the influenc e of ovarian somatic cells on the
improvement of metabolic health through transplantations of young, germ cell-deplet ed ovaries.
The purpose of this study is to expand the understanding of female reproductive health on
metaboli sm. Control mice were grouped by age and treatment mice were age-matched.
Treatment mice were placed into one of three groups: 1) mice received germ cell-depleted
ovaries, 2) mice received germ cell-containing ovaries, and 3) mice received ovarian somatic
cells via injection directly to their original ovary. All mice were subject to a glucose tolerance
test, during which a bolus of dextrose was administered, and blood glucose levels were collected
and recorded. Mice were euthanized between 680 and 700 days. Metabolic results showed an
impro veme nt of glucose metaboli sm in both germ cell-depl_eted and germ cell-containing groups
compa red to contro ls. No significance difference was noted between the germ cell-containin g
and germ cell-depleted groups. Somatic cell injection groups also showed improved glucose
metabolism compared to contro ls. This experiment has shown that post-reproductive health is
positively influenced by reproductive status. Additiona lly, somatic cells play an important role in
the restoration of health to post -reproductive mice.
Introduction
Menopause is defined as the period in women when menstrual cycles cease and is
characterized by reproductive decline. Menopause is additiona lly associated with a sharp decline
in many aspects of health. Before menopause, females hold a significa nt health advantage over
their male counterpa rts; however, post-menopausal females experience an increased risk of
disease compared to males of the same age. Menopau se is associated with increased
cardiovascu lar disease, increased risk of osteoart hritis, reduced muscular strength, and reduced
cognitive ability.
Menopause is associated with a decreased metabolism and an increased risk for metabolic
syndrome in a majority of wome n. Metabolic syndrome is characterized by increased weight
gain and lipid deposition , insulin resistance, and low glucose metaboli sm. Exist ing treatments for
menopause-related symptoms focus on hormone replacemen t therapy. Hormone replacement
therapy, while effective at treating some symptom s of menop ause, has not proven successfu l in
the treatme nt of metabolic disease or in the treatment of other menopau se-related health related
changes (Lobo, 2008).
Ovarian failure is associated with the failure and depletion of ovarian germ cells. Ovarian
somatic cells additionall y play a central role in health. Previous studies showed that germ celldepletion signifi cantly impro ves skeletal muscle enduran ce (Habermehl and Mason, 20 19). This
exper iment aims to evaluate the extent to which germ cells and somatic cells influence the
metabo lic decline assoc iated with menopause. In cur rent experiments, we chemicall y depleted
ovarian germ cells in pre -pubertal ovaries and evaluated glucose metabolism in young and postreproductiv e mice with and without ovarian germ cell-depletion. To further evaluate somatic cell
influence on post-reproductive health , we conducted somat ic cell injections into the ovary and
evaluated glucose metabolism.
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Materials and Methods
Female mice of the CBA/J strain were used in this experiment because they prematurely
lose their ovarian follicles, leading them to become reproductively senescent at approximately
300 days of age (Thung el al., 1956; Jones and Krohn , 1961; Faddy et al., 1987). A reduction in
the number of ovarian follicles in humans is associated with the onset of menopau se, and thus
was an ideal model in the study of age and menopause associate disease.
Female CBA/J mice aged 75 days, 200 days, 450 days, and 500 days were obtained from
Jackson Laboratory (Bar Harbor, ME, USA). The mice were housed in individual , ventilated
cages (Green Line IVC Sealsafe Plus, Tecniplast, West Chester, PA, USA). The laboratory
environment included fresh, filtered air ( 15 changes/h), temperature (21 ± 2 °C, humidity of 50 ±
20%), a light-dark cycle (12:12h), and a specific, pathogen-free colony. Corn cob bedding (7097
Corncob, Harlan Tecklad, Bartonville, IL, USA) was changed weekly. Cages also contained
deionized water and added enrichments. Mice were supplied with a certified laboratory diet ad
libitum (2018 Teclad Glodal 18% Protein Rodent Diet, Harlan Teklad, Bartonville, IL, USA).
Mice were maintained an American Association for Accreditation of Laborator y Animal Care
(AALAC)-approved facility in accordance with the National Institutes of Health animal-use
guidelines. Animal care and use protocols were developed under Nat ional Research Council
guideline s found in the Guide for the Care and Use of Laboratory Animals. This project was
appro ved by the Utah State University Institutional Animal and Care and Use Committ ee
(IACUC-2277).
Anesthetics were used for both donor and recipient mice that underwent surgery.
Analgesia was provided to recipient mice for 48 h post operation, or longer if deemed nece ssary .
Donor mice were euthanized via cervical dislocation. A thoracotomy was performed
immediatel y after cervical dislocation, followed by rapid exsanguination via cardiocentesis. Mice
with acute weight loss were treated with moistened food and subcutaneous fluids. Mice with
acute urine straining or rectal/vag inal prolapse were manually cleaned and treated with Desitin ®.
Mice were monitored at least twice a day and body weight was recorded monthly, more
frequently if concerns arose. Moribund, aged mice that exerted overt clinical signs (catatonia)
were euthanized. Criteria for euthanasia specific for aged mice were determined in coordination
with the attending veterinarian and included , but were not limited to, mice found in poor
condition with or without crusting around the perineum and diarrhea , urine staining, persistent
vaginal prolapse , chronic vulva/rectal swelling, kyphosis, respiratory distress , anorexia, poor
coat condition and lack of grooming, moribund mentation, hind-limb weaknes s/pare sis, wounds
not healing, limited mobility , neoplastic growth, and unusual weight loss (or gain). From peak
weight to death, aged, female CBA/J mice have an average weight loss of approximately 12%
per month (Mason et al., 2010) . An increased rate of w.eight loss , but not total weight loss, was
the most critical factor for determining a moribund state. Unexpected deaths were uncommon ,
but included neoplastic growths (most commonly mammar y), decubitus ulcers (extremely old
animals) and uncontroll ed cataleptic seizures (normally 11-13 months of age). Mice that received
germ cell-containing ovarian transpl ants lived on average 770 days. Mice that received ge1m
cell-depleted ovarian transplants lived an average of 898 (Mason, et.al 2011 ). In this study,
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control mice were euthanized at age 200, 300, 700, and 900 days. Treatment mice were
euthanized at 700 days.
Experimental Design
400-day-old mice were randomly selected as control, germ cell-containing transplant recipients,
and germ cell-depleted transplant recipients.
Controls
Control groups were created using the following criteria:
• 100-day-old mice that were reproductively cycling (n= 19)
• 200-day-old mice that were both acyclic and cyclic during the study (n= 10)
• 400-day-old mice that were acyclic (n=5)
• 600-day old mice that were acyclic and from a previous study (n=3)
Ovarian Transplant Groups
The ovarian transplant recipient groups were created using the following criteria:
• 400-day-old mice that were acyclic at the time of surgery and received 60-day-old
ovaries from donor mice that were cycling (germ cell-containing) (n=9)
• 400-day-old mice that were acyclic at time of surgery and received 60-day-old
germ cell-depleted (GD) ovaries from donor mice that were cycling (n= l 1)
Somatic Cell Injection Groups
Ovarian somatic cells were transplanted into the ovary using the following criteria:
• 400-day-old mice that were acyclic at time of surgery and received somatic cell
injections to both individual ovaries. Somatic cells were obtained from 60-day-old
mice that were cycling (n=5).
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Figure 1. 28-day-old mice with young ovaries (YO) were treated with 4-vinylcyclohexene
diepoxide (VCD) or Oil for 15 day. At 60 days of age, germ cell-depleted (GD) ovaries and
germ cell-containing (GC) ovaries were removed and transplanted into 400-day mice.
Unaltered ovaries from 28-day-old mice (YO) were digested and injected into the ovary and
ovarian bursa of 60-day -old somatic cell injection recipient mice (SCI). Mice metabo lism
was evaluated via glucose tolerance test starting at 460 days. Mice were collected when
treatment groups were 700± 10 days.

Age at Manipulation
Normally, CBA/J female mice become sexua lly competent at 45-60 days of age.
Manipulation was conducted at 28 days of age to avoid major up-regulation of the reproductive
system at the onset of puberty and to eliminate influences the female gonad might have in
addition to direct effects of gonada l hormones. Manipu lation was conducted by injecting a
placebo of sesame oil or treatment with 4-vinylcyclohexene diepoxide (VCD) to deplete germ
cells from young ovaries (n=20). Germ cell-depleted donor mice received injections
intraperitonea l of 160 mg/kg VCD once daily for 15 days. A previous 15-day VCD dosing
protocol was created to stop reproductive cycling and deplete ovarian primordial and primary
follicles (Mason, et.a l 2009).
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While rodents do not undergo menopause, they do have an estropause-Iike decrease in
reproductive function . This decline in reprodu ctive function begins at arou nd 240 days of age
and decrea ses gradually until reproductive incompetence at 330 days of age (Mason, Parkinson ,
Habermehl, 2018).
Surgical Procedures
Ovarian Transplants
Female mice of the CBA/J strain become reproducti vely active between 45-60 days old.
At 60 days of age, cycling was confim1ed in donor mice, and donor mice were anesthetized and
had their ovaries remov ed. Cycles were confirmed using vaginal lavage. Donor mice were
euthani zed via cervical dislocation following removal of ovaries.
Recipient mice underwent ovarian transplant surgery and received donor ovaries as
previously described (Mason, Cargill, Anderson, 2009) . Briefly, mice were anesthetized, and a
vertica l incision was made in the lateral aspect of the abdomen . The ovarian fat pad was
externalized, and a small opening was made in the ovarian bursa. The ovary was extracted and
the donor ovary was placed within the empty ovarian bursa . The ovarian bursa was replaced
within the body and the abdomen was sutured. The skin was stapled closed. This procedure was
performed on both the left and right ovaries. All mice were allowed to recover for one month
before metabolism was measured .

Injections
At 60 days of age, cycling was confirmed in donor mice, and donor mice were
anestheti zed and had their entire reproductive tract removed . Cycles were confirmed using
vaginal lavage. Donor mice were euthanized via cervical dislocation following removal of
ovan es.
Ovaries were isolated from the ovarian bursa from donor mice and placed in a glass
convex dish. 50ul of digestion buffer (1 % collagenase V, 100U DNase, 1% dispase with 290ul
PBS+) was added, and ovar ies were manually torn with 19 gauge needs for 5 minut es. Ovary
solution was then placed into a 1.5mL Eppen dorf tube. 100ul buffer was used to was h the glass
dish and added to Eppendorf tube. Anoth er 345uL digestion buffer was added to the ovary
solution , tot al fluid within the tube at 500uL. Ovary solution was incubated at 37°C for 5 minut es
with frequent pipetting, and 5 minutes with mild pipetting. 500uL of serum-conta ining media
was added to the solution and allowed to sit for 5 minutes. The solution was spun down at 500g
for 5 minutes. The supernata nt was again removed, and pellet was resuspende d with 1.0mL
PBS-. The ovary solution was filtered through a 40um filter into a 50mL tube and spun down at
500g for 5 minute s. The supernatant was again removed, and remaining pellet was resuspended
in 500uL of germ cell culture media containing a ZVF and AA V-GFP marker. Cells were plated
in the first well of a four-well-plate and cultured overnight at 38°, 6% CO2. The next day, media
was removed and deposited into the third well. The original well was rinsed twice with
PBS/BSA, after which l00uL of 0.25% trypsin/EDT A was added and allowed to sit for up to 10
minutes. After cells have rounded, 400uL of germ ell media was added to the well and pipetted
to a single cell suspension. 500uL was then added and suspension was incubated for 6 hours.
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Pure somatic cells were created in the first well in this way and were used in somatic cell
injection s.
Female mice were injected with ovarian somatic cells as previously done. Briefly,
surgical proc edures to externali ze the ovary were performed using the same operating procedure
as ovarian transplant s. Instead of removing the ovary, somatic cells were transported via a
microinjection needle into the ovary and ovarian bursa. The ovary was then returne d to the
abdomen wall. This procedure was done for both ovaries. The abdomen was sutured closed and
the skin was closed with skin staple s. Mice were allowed to recover for one month before
metabolism was evaluated.
Exclusion Criteria
Exclusion frorn analysis was based on gonadal input, defined as cyclic changes on
vaginal cytology , presumably due to the cyclic influence of ovarian horm ones. Absence of
gonadal input was assumed to be indication of the lack of cyclic influence of ovarian hormones.
Cycling was determined by vaginal lavage. Control mice that displayed cytological evidence of
gonadal input 13 months of age or prior to surgery at 17 months of age were excluded from
analysis. Ovarian transplant recipients that failed to display evidence of gonada l input
postoperatively were also excluded from analysis. ·
Metabolic Function-Glucose Test
An intraperitoneal (IP) glucose tolerance test (OTT) was performed in mice that were
feed-deprived for 4-5 hours previous. Fasting time was selected based on metabolic differences
between mice and humans and due to aged female's intolerance to overnight fasting (Ayala, et.al
20 10). Blood glucose levels were measured using FreeStyle Freedom Lite Blood Glucose
Monitoring System (Abbott Diabetes Care Inc. Almeda, CA, USA). Blood samples were
obtained from a small nick at the tip of the tail, 2 h prior to testing and again immed iately prior
to glucose administration (tO), and at 15, 30, 60, 90, 120, and 180 minute s after injection.
Glucose inj ection consisted of 20% D-glucose (2.8 g/kg lean body mass). Cali bration of the
FreeStyle Freedom Lite Blood Glucose Monitorin g System was perfo rmed using control test
solutions provided by the manu facturer.
Two drops of blood were collected, the first of which was discarded. The second drop
was placed on the FreeStyle Freedom Lite test strip . Blood glucose reading was expressed as
mg/dL. Glucose measurements at each point were then graphed and results expressed as Area
Under the Curve (AUC).
Statistica l Analysis
Statistical analysis was performed with GraphPad Prism 7.04 (GraphPad Software, Inc.,
La Jo lla, CA, USA) . D' Agosti no-Person Omnibus test was perform ed to determine normality.
Data were analyzed with a two-factor AN OVA and a Tukey -Kramer po st-hoc test was used to
determ ine differences between the groups. Student's two-t ailed t-test was perfonned on
individual treatments assum ing unequal distribution of var iance. Test results were considered
significant for P values P<0.05.
-8-

Results

-----

AUC
2000

Very Young 168 Days
Young 251 Days

1500

Age Match 598 Days

g 1000
<(

Very O ld Green 841 Days

3: a;

GC 543 Days

500

GD 534 Days
OSC 490 Days

Group

Figure 2 . Area Under the Curve (AUC) for young, old, age match, and very old control groups,

and for germ cell containing (GC), germ cell-depleted (GD), and ova rian somatic cell injection

(OSC) groups.

Average Blood Glucose Curve

i

-

300
GC (534 d)

0,

-

E 250

GD (534 d)

1/)

ci>200
>
Q)
...J
Q)
1/)

OSC (490 d)

150

Very Young (168 d)

8:::, 100
(!)

Young (25 1 d)
Age Match (598 d)

50

"C

Very Old (841 d)

0

~

m

0+---,----.----r----r--..-----,
1
2
3
4
Minutes

5

6

7

Figure 3. Blood gluco se levels in mg/dl across time.

-9-

Blood glucose levels for each treatment and control mouse was mapped in mg/dL against
time. Averages were also charted, as seen in Figure 3. At t= 15 minutes, all mice groups
experienced peak blood glucose levels. As seen in figure 3, Old Control mice on average peaked
higher than other treatment and control groups after 15 minutes post-glucose injection.
Additionally, the curve remains high as the glucose is metabolized , finally falling to similar
levels to other groups after 90 minutes. The three other groups, Oil Control , Age Match Control,
and GD Treatment groups follow similar curves . GD and GC both exhibited lower levels of
blood glucose than the Age Match controls.
Young mice glucose metabolism exhibited a low area under the curve (AUC). As age of
control mice increased, the area under the curve also increased. Very old mice (age 841 days)
exhibited the highest area under the curve. Germ Cell-Containing (GC) Treatm ent group
exhibited significantly lower AUC than the Age Match Control group (p < 0.012). Values were
considered significant at p<0.05. The AUC of the GD and GC was only slightly elevated over
Young Control mice. GD mice , despite having an AUC below that of the Age Match controls,
were not significantly different (p=0.3). There was no significant difference between the GD and
GC treatment groups (p=0.06). While comparable levels, no significant conclusions can be
drawn between these two groups.
Ovarian Somatic Cell Injection (OSC) Groups also exhibited lower blood glucose level
peaks compared to Old Controls, Age Match Controls , and Young Controls. OSC did not have
an AUC significantly lower than Age Match Controls (p=0.657). Additionally, OSC did not have
a significant AUC compared to GD Treatment (p=0.343), nor did OSC have a significant AUC
compared to GC (p=0.087).
Discussion
As females age, glucose intolerance increases. This intolerance can be characterized by a
dramatic increa se in blood glucose levels above fasting blood glucose levels after food
consumption, as well as by an increased recovery time after food consumption for blood glucos e
levels to return to resting levels. A decrease in metabolic efficacy leads to other health problems ,
including metabolic syndrome and diabetes. These conditions can cause a decline in quality of
life as well as overall lifespan. Loss of metabolic function has been previously associated with
the loss of ovarian function in post-menopausal mice (Romero-Aleshire, M.J et. al, 2009).
Our control groups follow an expected trend following that of a metabolic curve in postreproductive women. As the age of mice increased , so also did circulating blood glucose level
and subsequent Area Under the Curve (AUC). Old mice exhibited a less efficient metabolic
system, as can be seen both in Figure 2 and Figure 3. In both these Figures , the Area Under the
Curve for old mice (age 841 days) is elevated beyond that of Age-Match Control (age 598 days)
and Young Mice Control (age 168 days) groups. Elevated circulating blood glucose levels is a
risk factor for disease and often leads to insulin resistance, leading to metabolic syndrom e, and is
seen in the old mice comparable to a naturally occurring menopause in women.
GD and GC groups both had reduced circulating blood glucose levels compared to their
age match counterparts, suggesting that germ cells and somatic cells play a role in overall postmenopausal health. While conclus ions are not statistically supported for GD vs. Age Match
controls, the general trend may lead to an understanding about somatic cells in post-men opausal
- 10 -

health. The Somatic Cell Injection (OSC) group similarly had reduced levels. These results
suggest there is a potential treatment option for menopause-related health decline directed at
somatic cell therapy.
Currently , control of menopause-related symptoms has been addressed using Hormon e
Replacement Therapy (HRT). Few studies have been conducted on the effect ofHRT on
metabolism of post-menopausal women, but existing studies show mixed results and no proven
treatment for metabolic syndrome or resistance (Lovre , 2017). HRT typically targets the
hormone estrogen, which is decreased during menopause. Germ cells produce aromatase, which
converts androgens to estrogens. Our research suggests that while germ cells may contribute to
menopause hormone changes , these changes may not be exclusive in affecting overall metabolic
health. Becau se both germ cell-depleted and somatic cell injection groups experienced improved
metabolic health over old and age-match control groups, we propose that somatic cells also play
a critical role in metabolic health. As a result , HRT may be less effective in correcting the
decline in metabolic health due to the fact that somatic cells largely lack production of the
hormone s augmented by this therapy. We propose that ovarian somatic cell-based treatmen t may
be more effective at treating metabolic decline than HR T. While this study lacked the direct
evaluation of hormone, further studies will be conducted to test this idea.
Overall , young ovarian transplantation has a positive influence on glucose metabolism.
GC groups confirm reduced blood glucose levels in post-reproductive mice. No statistical
suppor ted conclusions can be concluded for OSC and GC groups. In addition to this finding,
somatic cell injections also had a positive influence on glucose metabolism. All treatment groups
(OSC, GD, GC) showed reduced blood glucose levels.
Glucose metabolism is only one part of the complex metabolic system influenced by
menopause. Continued studies in other aspects of metabolic health of po st-reproductive mice
have the potential to increase underst anding of the roles somat ic and germ cells. Future studies in
this lab invol ve evaluating circulating triglyc eride levels of GC, GD, and OSC mice to
understand if germ cell-depletion influence triglyceride levels.
Conclusions
While women are living longer , the age of onset of menopau se has stayed relati vely
constant. The relation ship between somatic cells and germ cells in overall health is complex and
still not well understood. Women are living longer with menopause and with the health decline
associated with menopause . A health decline is associated with menopause that includes the
decline in glucose metabolism. The decline in the efficacy of glucose metabolism may be
improved with young ovaries that have been germ cell-depleted.
Additionally, somatic cell injection s proved to be successful in restor ing glucose metabolism.
This understanding has the potential to develop a somatic cell treatm ent for post-menopausal
metabolism conditions. In developing existing understanding of somatic and germ cell
communic ation , the hope is to develop a treatment to restore the health of post-menopausal
women.
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Reflective Writing
Kyleigh Tyler
My capstone project has significantly impacted and built upon my education at Utah
State University. My path in research started my very first semester here, where I became
involved with Dr. Benningholf's nutrition lab. After attending a guest lectur e by Dr. Mason, I
joined his lab which focuses on menopause, longevit y, and reproduction. My capstone project
combined these two experiences as I chose to focus on metabolic changes associated with
somatic cells in ovaries. I was able to keep the contacts I had from Dr. Benningholf's nutrition
lab as well as the knowledge I had learned in the development of my own project. My capstone
project was effectively the perfect culmination of my education.
In addition to the knowledge I learned from paiiicipating in multiple labs, my research
has helped me to apply the knowledge I've learned in my animal science classes. Because my
capstone project has combined two major disciplines - nutrition and reproduction - these classes
specifically have helped me understand the technical processes within my project. In addition,
my endocrinolog y class was essential in developing a working knowledge of my project. There
were many technical terms, processes, and procedures I had to learn. I was able to bring my
unique experiences into the classroom. In under stand ing the details of these physiological
proce sses, my classwork came to life and my knowledge was enriched.
There were some challenges that were presented in accomplishing my capstone. I
finished experiments involvin g glucose early in thi s semester. Originally, I had planned to also
analyze triglyceride deposits within our mouse serum and compare the two sets of data for one
group of transfer mice. While the actual experiments were completed, analyzing data proved to
be unrewarding. Despit e my efforts and the efforts of those in my lab, our data was not showing

an expected trend. While the data was sound, the way we analyzed it was simply not working.
Thus , my final paper is a reflection on glucose data from multiple groups of mice, which also
showed an interesting trend. We have been working on analyzing this data in multip le ways,
including pulling the opinions of different departments. We just recently, through collaboration
and varying perspectives, discovered a flaw in within our Excel programing, and while I was not
able to continue with my initial capstone plan , the research I've done can continue to grow.
Being able to adapt was crucial to my project and was a valuable lesson learned in research.
Often, research is unpredictable, and the ability to adapt is essentia l in a researcher. I learned
how to overcome these challenges, which enriched my capstone experience.
The most rewarding pa11of my research was seeing the data give a staggering trend , a
trend that has thus far been undocumented and has far reaching implications. Understanding the
cells of the ovaries and how they influence health has the potential to help millions of people. To
me, this is the most exciting thing about research, and something I' d like to dedicate my life to. I
had no idea before entering college that such cutting-edge research was happening right here in
Utah. My advice to future stude nts is to be engaged in research that is happening, and don ' t be
afraid to spend time in different labs. My experience in two labs combined perfectly to lead to
my capstone project, and both labs were conducting research I was interested in. Being able to
both combine my passions and discover new passions was a highlight of my capstone project.
While Dr. Mason's lab is under the Department of Animal, Dairy, and Veterinary
Sciences, the students in our lab were diverse and from different backgrounds. Diversity within
the lab helped me develop ideas and overcome challenges through collaboration. For examp le,
two graduate students and a laboratory technician were available to teach me different
procedures. Undergraduate s students in the lab had majors in animal science, veterinary science ,

and biology. Additionally, two vet students were periodicall y assigned to assist on project s. With
so many different background readily available , multidisciplinary collaboration was easy and
provided essential insight, especially in constructing my project. Collaboration was often
facilitated during weekly lab meetings, where each of us brought current issues in our projects
for discussion. Weekly meetings helped me to think critically and call on additional knowledge
from all members of our labs.
One of the greatest experiences I had while conducting this research was the opportunity
to share it with others within my community and beyond. This semester alone, I was able to
present to State Representatives at the Utah State Capitol as part of Research on Capitol Hill, at
the Western Regional Honors Conference held in Bozeman, Montana, and at the National
Conference on Undergrad uate Research held in Atlanta, Georgia. I was able to discuss my
research with students from a variety of backgrounds , but often with students who shared a
passion for human health. Research on Capitol Hill was a unique outlet for me to share my
research with the community. I presented my research to representatives and to the general
public of Utah. In this way, I had the opportunity to share my capstone with my immediate
community.
Throughout my research experience, I have learned much about academia , careers in the
field of veterinary medicine, and how to solve problems. While I knew coming into college that I
wanted to become a veterinarian, I was unaware of the sheer number of roles a veterinarian could
take. As I conducted research, specifically as I completed my own project , I was exposed to
many of these roles. This realization of the far-reaching possibilities was perhaps the biggest
benefit to my capstone project. As I attend veterinary school in the coming years, I plan to
pursue a Master's or PhD degree in addition to a DVM degree. Research has had such a

profound impact on my life. Creating my own project and engaging in research from start to
finish has helped me decid e to pursue a career in research as a research animal veterinarian . My
capstone project was imperative in shaping this decision.
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